Testagen 20mg Research Peptide
Testagen is a 4-amino-acid synthetic peptide (Lys-Glu-Asp-Gly) derived from the Khavinson short-peptide line of organ-specific bioregulators. It is the prostate/urogenital-tissue counterpart to other Khavinson tetrapeptides such as Epitalon (pineal) and Bronchogen (lung).
Purity
99.0% HPLC-tested purity with COA support.
Size
20mg Lyophilized Powder.
Storage
2–8°C (Refrigerator)
Research use
For laboratory research use only. Not for human or veterinary use.
Mechanism of action
Testagen is hypothesized to act at the transcriptional level in prostate and urogenital tissue, modulating expression of genes involved in epithelial proliferation, secretory function and androgen-axis regulation. Russian-language gerontology literature reports improvements in age-related prostate function markers at low repeated doses.
Research applications
- Prostate and urogenital research
- Male reproductive and hormonal-axis studies
- Healthy-aging and male-longevity research
- Khavinson tetrapeptide bioregulator pharmacology
- Tissue-specific gene-expression studies
Frequently asked questions
What tissue does Testagen target?
In published Khavinson-group research, Testagen is the prostate/urogenital-tissue bioregulator of the short-peptide family — analogous to how Epitalon targets the pineal gland and Bronchogen targets bronchial epithelium.
Is Testagen androgenic?
No. Testagen is a 4-amino-acid peptide that modulates gene expression in prostate and urogenital tissue, rather than acting as an exogenous androgen. It is studied for tissue-specific regulatory effects, not steroid replacement.
Is your Testagen third-party tested?
Yes — every batch ships with HPLC verification at ≥99.0% purity, mass-spec identity confirmation and a batch-specific Certificate of Analysis.
Browse research peptides for sale · View lab reports · Read peptide FAQ